March, 26 2026 Thursday 15:50 Hrs
Last update 11-9-2025
  • SENSEX :   75,273.45

  • Commodity broking firm in India1,205.00( 1.63%) 25-Mar-2026
top-arrow-market
Sensex 75273.45 1205.00  (1.63) 25-Mar-2026
Previous Day Close
74068.45
Today's High/Low
High Low
  •  
  •  
75849.76 74550.47

Company News Details

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
461.79599
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
11.63
17440.82
EPS(TTM)
Face Value()
Div & Yield %
83.75
2
0.62
 

natco pharma ltd
Natco Pharma receives CDSCO approval for launch of Semaglutide in India
Feb 14,2026
Natco Pharma received approval for Semaglutide from Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide Injection in India. NATCO will launch the product in the India market in March'26.

Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.